Beyond protection: Turning patent portfolios into commercial advantage

​
November 12, 2026

Why the strongest patent strategies begin with business value - not patent volume

The proposition

A patent portfolio can be legally impressive and commercially disappointing. The real test is not how many patents a business owns, but what those patents enable it to do. For many organisations, patents are still viewed primarily as defensive legal tools. But in today’s innovation-driven economy, the strongest portfolios do much more: they support growth, investment, partnerships, valuation and competitive advantage.

Patents remain important defensive rights. They can deter copying, create barriers to entry and provide leverage when a competitor gets too close. But protection is only the starting point. A portfolio creates real value when it is connected deliberately to the company’s products, markets, funding strategy and commercial relationships. Without that connection, even technically strong patents can become an expensive record of past innovation.

1. A patent is not valuable merely because it has been granted

A grant certificate proves that a legal threshold has been met. It does not prove that the patent protects a product customers want, covers a commercially important market or would survive a determined validity challenge.

That distinction matters because patents are expensive throughout their life. Filing, prosecution, overseas protection, translations, renewals and enforcement all compete for capital. The objective should not be to accumulate rights, but to build a portfolio whose scope, ownership and geographic coverage support a credible commercial position.

Nor is quantity a reliable proxy for strength. Five well-chosen patent families may do more for a business than fifty peripheral filings. Value depends on what the claims cover, how difficult they are to design around, whether the rights align with the market and whether the business can use them in practice.

The strongest portfolios are built with the end goal in mind from the beginning.

2. Start with the commercial objective

In my experience, the most productive patent discussions begin not with “Can we patent this?” but with “What commercial position are we trying to create?”

That question changes the conversation. It requires the business to identify the products and services that matter, the markets it expects to enter, the competitors or partners it may encounter and the capabilities that genuinely differentiate it. Filing decisions can then be tested against those objectives rather than driven by technical novelty alone.

This is critical in deep tech: quantum, artificial intelligence, life sciences, semiconductors and advanced engineering, where technologies and business models can evolve faster than the patent process. The portfolio must move with the business - not anchor it to an obsolete roadmap.

3. Use patents to create options: investment, licensing and partnerships

The commercial power of a patent is often its ability to create options. For an investor or acquirer, a coherent portfolio can evidence ownership, technical differentiation and a disciplined approach to future growth. It can support valuation, although it does not determine valuation on its own.

Patents can also make collaboration easier. Clearly defined rights help parties understand what each is bringing to a joint development, what access is required and how resulting technology may be commercialised. That clarity can reduce friction in negotiations with larger industrial partners, research institutions and other members of an innovation ecosystem.

Licensing adds another route to value. A business need not manufacture every product or enter every territory itself. Rights that are peripheral to one company’s strategy may be central to another’s. But licensing revenue is not automatic: it depends on market demand, useful claim scope, credible ownership and a counterparty with a commercial reason to take a licence.

4. Review ruthlessly: quality, relevance and cost

A portfolio should not be treated as a museum. Products change, markets close, competitors move and once-promising technologies lose relevance. Regular review is therefore as important as initial filing.

Each patent family should earn its place. Does it still support a current or credible future product? Is the protected market important? Does the right constrain a competitor, strengthen a negotiation or offer a realistic licensing opportunity? Are the likely benefits proportionate to the next round of prosecution and renewal costs?

Where the answer is no, sale, licensing or abandonment may be the disciplined choice. Pruning is not a sign that the original filing failed. It is evidence that the portfolio is being managed as a business asset.

5. Protection is only one part of the IP strategy

A balanced and credible strategy also recognises what patents cannot do. Patent ownership does not establish freedom to operate: a business may own valuable rights and still risk infringing an earlier third-party patent. Nor is patenting always the best answer. Filing requires disclosure, enforcement can be costly and some innovations are better protected through confidentiality, accumulated know-how, contractual controls, data advantages or speed to market.

The right question is therefore not whether patents are inherently valuable. It is where they add value relative to the alternatives. For some technologies, a patent will be the foundation of market exclusivity. For others, it will be one element in a broader package of rights and practical barriers that competitors cannot easily reproduce.

6. Conclusion: make the portfolio work for the business

The strongest patent strategies are neither filing exercises nor defensive reflexes. They are commercial disciplines. They connect protection decisions to products, markets, capital, partnerships and competitive choices - and they change when the business changes.

That means filing selectively, documenting ownership, reviewing the portfolio honestly and being clear about the outcome each right is intended to support. It also means recognising when another form of protection would serve the business better.

The goal is not simply to own patents. The goal is to make the portfolio work for the business.

Turn your patent portfolio into a commercial asset

Looking to get more value from your patents? Talk to our team about developing a patent strategy aligned with your commercial ambitions.

The Latest Thought Leadership pieces in the Content Hub

No items found.
Stay in the Know

The Patent Strategist

Get expert insights and the top patent stories delivered straight to your inbox.

Heading
This is some text inside of a div block.
This is some text inside of a div block.

Latest Insights

Showing 0 of 100
Opt-out decision
02 December 2022
Owners of European patent rights (both pending and granted patents) need to decide, in respect of each right individually, whether to opt out of the Unified Patent Court ("UPC") system.
#
Litigation
​
Information from the UPC Registry
01 December 2022
The Registry of the Unified Patent Court maintains a number of Registers which are publicly accessible via their website at www.unified-patent-court.org.
#
Patenting
​
Unitary Patent as an object of property
09 November 2022
A registered intellectual property right such as a patent is normally considered a property right of the country in which it has effect. Rules relating to the patent as an object of property, for...
#
Patenting
​
What are the options if you want to avoid the UPC?
03 November 2022
During the transitional period, it is possible to opt classical (i.e. non-unitary) European patents and applications out of the competence of the UPC (provided that no action has commenced at the UPC...
#
Patenting
​
What are the options if you want to be able to use the UPC?
03 November 2022
All unitary patents fall within the competence of the Unified Patent Court (UPC). Additionally, classical validations of European Patents in states which have ratified the UPC agreement are within...
#
Patenting
​
What is the Unified Patent Court?
01 November 2022
The Unified Patent Court ("UPC") is a new pan-European court which opened for business on 1 June 2023. It adjudicates disputes relating to the new Unitary Patents and also to existing and future...
#
Litigation
​
What is the Unitary Patent and how do I get one?
01 November 2022
The Unitary Patent (UP) is a single patent right, obtained via the European Patent Office, covering all EU Member States which have ratified the agreement at the patent grant date, and is subject to...
#
Patenting
​
How does the opt-out work?
01 November 2022
The Unified Patent Court (UPC) will ultimately be responsible for all litigation in participating member states relating to patents granted by the European Patent Office (EPO); national courts in...
#
Patenting
​
What languages does the UPC use?
01 November 2022
Central Division Proceedings at the central division are in the language in which the patent was granted (i.e., either French, German or English).
#
Patenting
​
IP considerations arising from increased micro mobility competition
24 June 2022
Following the Queen's Speech, and years of consultations and lobbying from the micro mobility sector, it looks like the e-scooter industry is in for a bumper year.
#
Patenting
​
Are open-source patent portfolios the key to the EV revolution?
16 June 2022
The widespread rollout of electric vehicles is viewed as a crucial part of the UK's green revolution. When discussing how this can be achieved, charging infrastructure is often cited as the key to...
#
Patenting
​
What is the likely timing of the UPC and UP coming into being?
09 June 2022
The Unified Patent Court (UPC) is currently completing preparations to be open for business (under the Protocol on the Provisional Application of the UPC Agreement (the ‘PAP-Protocol')).
#
Litigation
​
The Unitary Patent System is on the way
20 January 2022
We reported last year that the Unitary Patent and Unified Patent Court (UPC) were progressing. The main hurdle left to clear was sufficient countries ratifying the Protocol on the Provisional...
#
Litigation
​
Hybrid event: Healthcare Innovation & Strategy Series - IP Strategy Beyond Drafting Patents
19 October 2021
We would like to invite you to join us for the second part of our life science and medtech event on 09 November where we will continue to explore upcoming trends in IP and healthcare.
#
Patenting
​
Unlocking healthcare with AI
16 September 2021
Much has been written about the development of artificial intelligence (AI) and its potential to reshape everyday life.This potential is already being realised in healthcare, with health...
#
Patenting
​